Heron Therapeutics Balance Sheet - Annual (NASDAQ:HRTX)

Add to My Stocks
$33.8 $0.85 (2.45%) HRTX stock closing price Sep 17, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Heron Therapeutics balance sheet. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Heron Therapeutics stock analysis. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The Heron Therapeutics balance sheet for 2017 shows total assets of $234.3M. The company has a asset turnover ratio of 0.2. Also see: Heron Therapeutics revenue and Heron Therapeutics operating cash flow for the same year.

View latest 10 year balance sheet data to check Heron Therapeutics financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Marketable Securities27.79M37.72M55.98M-------
Raw Materials2.75M1.64M--------
Work In Progress4.16M1.1M--------
Finished Goods3.18M2.58M--------
Notes Receivable----------
Other Current Assets3.7M3.7M3.58M1.05M------
Total Current Assets
Property Plant & Equipment13.84M11.69M8.6M7.65M7.15M6.15M5.35M4.51M4.63M4.64M
Accumulated Depreciation7.85M6.61M5.55M4.83M4.27M4.4M4.28M4.15M4.12M3.76M
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable28.68M2.91M2.22M1.59M1.02M-----
Accounts Payable18.76M6.81M3.3M2.54M1.26M1.91M1.01M---
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses52.95M27.9M14.21M9.47M4.7M1.75M2.58M1.16M1.63M2.84M
Income Taxes Payable----------
Other Current Liabilities2.76M1.09M--------
Total Current Liabilities
Deferred Taxes/Income---------1M
Convertible Debt----------
Long-Term Debt-50M--------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net-----3.02M2M---
Capital Surplus913.95M564.34M530.61M378M307.57M232.38M173.98M149.34M147.48M138.38M
Retained Earnings-783.45M-585.97M-412.82M-315.23M-238.87M-183.58M-160.23M-148.42M-141.07M-131.05M
Treasury Stock----------
Other Liabilities-0.01M-0.01M-0.04M-------0.04M
Shareholders Equity131.13M-21.25M118.11M63.06M68.94M51.81M15.75M1.31M6.79M7.59M
Total Liabilities & Shareholders Equity234.3M67.48M137.84M76.68M75.93M55.97M19.44M2.91M8.95M11.8M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the Heron Therapeutics stock price by looking at Heron Therapeutics historical stock prices. One can compare PE with industry average by looking at the Heron Therapeutics PE ratio chart. The common balance sheet items are:

  • Assets: HRTX total assets, which was at $234.3M for 2017 is a balance sheet item representing value of what Heron Therapeutics owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Heron Therapeutics's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for HRTX stock stand at $103.17M.

Heron Therapeutics Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio